Cisplatin

BCL2 like 11 ; Homo sapiens







12 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34160887 The lncRNA 'UCA1' modulates the response to chemotherapy of ovarian cancer through direct binding to miR-27a-5p and control of UBE2N levels. 2021 Dec 1
2 30614795 The ratio of Bcl-2/Bim as a predictor of cisplatin response provides a rational combination of ABT-263 with cisplatin or radiation in small cell lung cancer. 2019 6
3 29196192 Macrovipecetin, a C-type lectin from Macrovipera lebetina venom, inhibits proliferation migration and invasion of SK-MEL-28 human melanoma cells and enhances their sensitivity to cisplatin. 2018 Mar 1
4 29060932 miR-34a increases cisplatin sensitivity of osteosarcoma cells in vitro through up-regulation of c-Myc and Bim signal. 2017 Dec 12 4
5 26503209 Knockdown of miR-221 promotes the cisplatin-inducing apoptosis by targeting the BIM-Bax/Bak axis in breast cancer. 2016 Apr 2
6 26171069 Synergistic effects of cisplatin and proteasome inhibitor bortezomib on human bladder cancer cells. 2015 Jul 1
7 24814195 FOXO3a mediates the cytotoxic effects of cisplatin in lung cancer cells. 2014 Sep 1
8 24854555 [MiR-192 confers cisplatin resistance by targeting Bim in lung cancer]. 2014 May 2
9 22131152 Histone deacetylase inhibitor potentiates chemotherapy-induced apoptosis through Bim upregulation in Burkitt's lymphoma cells. 2012 Feb 1
10 21561860 Bim protein degradation contributes to cisplatin resistance. 2011 Jun 24 10
11 21655183 BIM-mediated AKT phosphorylation is a key modulator of arsenic trioxide-induced apoptosis in cisplatin-sensitive and -resistant ovarian cancer cells. 2011 2
12 21156403 Reduced expression of Bax in small cell lung cancer cells is not sufficient to induce cisplatin-resistance. 2010 Oct 25 1